% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fib1_1_2_3_5 fib1_1_2_3_5 Oct 10, 2011 6:23 PM Flag

    Anyone heard the webcast?

    Just listened. The only comment I heard was on Rindo in that the combo trial with Avastin could lead to a faster path to approval. No timeline, but it would certainly not be in 2012.

    The trial is a randomized P2 in recurrent glioblastoma. I assume that he is saying that in this setting there is more of an unmet need, thus the FDA could accept this P2 data for (accelerated?) approval.

17.89+0.10(+0.56%)Nov 25 4:00 PMEST